Iceland – Pharmaceutical products – Ýmis lyf 89 Innrennslislyf og skolvökvar
Landspítali Háskólasjúkrahús
Buyer country
Iceland
Publication date
01 September 2026
Biderra sector
Pharma and laboratory
Data source
TED open data
Decision signals
First-pass opportunity review
These signals are calculated from the indexed fields. They help prioritize a review but do not replace eligibility checks in the official procurement documents.
- Timing signal
- 8 days to indexed deadline
- Indexed data completeness
- 86%
- Official title coverage
- 7 languages
- Classification signal
- 33600000
- 90-day market activity
- 4 related notices
- Buyer activity
- 6 indexed notices
09 September 2026
Based on seven decision fields
Preserved from source-supplied versions
Medical equipment, pharmaceuticals and personal care products
1 buyers in Iceland / Pharma and laboratory
Published by this buyer in the last 90 days
Market context
How this notice compares with the current market
Biderra found 4 pharma and laboratory notices from Iceland in its rolling 90-day index. 0% publish an estimated value and 25% include at least one indexed deadline. This notice is currently active according to the deadline fields available in the source feed.
Recent notices
4
Value disclosed
0%
Deadline coverage
25%
Official title versions
TED may publish the same notice title in several official languages. Biderra preserves the versions supplied in the source feed.
Islandia – Productos farmacéuticos – Ýmis lyf 89 Innrennslislyf og skolvökvar
IJsland – Farmaceutische producten – Ýmis lyf 89 Innrennslislyf og skolvökvar
Islandia – Produkty farmaceutyczne – Ýmis lyf 89 Innrennslislyf og skolvökvar
Islande – Produits pharmaceutiques – Ýmis lyf 89 Innrennslislyf og skolvökvar
Island – Arzneimittel – Ýmis lyf 89 Innrennslislyf og skolvökvar
Islanda – Prodotti farmaceutici – Ýmis lyf 89 Innrennslislyf og skolvökvar
Iceland – Pharmaceutical products – Ýmis lyf 89 Innrennslislyf og skolvökvar
What Biderra adds
For notice 601277-2026, Biderra has normalized the contracting authority country as Iceland, grouped CPV 33600000 under pharma and laboratory, compared the available deadline fields with today, measured field completeness, and preserved 7 source-supplied title versions. The official record remains decisive.